Last 12 months
Inside the activity.
0 purchase rows · 116 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 17 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 23 |
| May 2026 | 0 | 15 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 41 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 8,282 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 21 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,837 Underlying: Common Stock · 8,282 shares Expires 2033-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 8,282 | $65.07 | $538,917.19 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 14 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,066 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F9 · price: The weighted average sale price for the transaction reported was $65.0709, and the range of prices were between $65.00 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 8,282 | $22.40 | $185,516.80 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 13 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 108,493 | $0.00 Strike: $23.34 | $0.00 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · derivative · entry 14 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,493 shares Expires 2029-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 6,802 | $64.95 | $441,795.34 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 11 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,886 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F8 · price: The weighted average sale price for the transaction reported was $64.9508, and the range of prices were between $64.84 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 101,691 | $64.59 | $6,567,875.94 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 10 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,688 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F7 · price: The weighted average sale price for the transaction reported was $64.5866, and the range of prices were between $63.84 and $64.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 17, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 108,493 | $23.34 | $2,532,226.62 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 9 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 57,500 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 16 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 57,500 shares Expires 2031-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 55,000 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 15 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 350 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 14 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 350 shares Expires 2029-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 47,746 | $63.61 | $3,037,247.20 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 11 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,197 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F7 · price: The weighted average sale price for the transaction reported was $63.6126, and the range of prices were between $63.47 and $63.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 65,104 | $63.12 | $4,109,397.03 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 10 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,943 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F6 · price: The weighted average sale price for the transaction reported was $63.1205, and the range of prices were between $62.47 and $63.4650. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 57,500 | $26.88 | $1,545,600.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 9 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 55,000 | $15.46 | $850,300.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 8 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 350 | $17.96 | $6,286.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 7 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 17,717 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 20 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 500 Underlying: Common Stock · 17,717 shares Expires 2031-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 55,000 | $0.00 Strike: $15.46 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 19 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 55,000 shares Expires 2030-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 100,000 | $0.00 Strike: $11.25 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 18 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2029-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 79,113 | $63.65 | $5,035,906.37 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 12 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,066 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F8 · price: The weighted average sale price for the transaction reported was $63.6546, and the range of prices were between $63.50 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 93,604 | $63.25 | $5,920,181.55 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 11 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 196,179 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F7 · price: The weighted average sale price for the transaction reported was $63.2471, and the range of prices were between $62.50 and $63.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 17,717 | $26.88 | $476,232.96 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 10 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 289,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 55,000 | $15.46 | $850,300.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 9 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 100,000 | $11.25 | $1,125,000.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 8 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 195,841 | $0.00 Strike: $23.34 | $0.00 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · derivative · entry 13 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,493 Underlying: Common Stock · 195,841 shares Expires 2029-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 96,125 | $63.64 | $6,117,289.26 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 8 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,886 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F6 · price: The weighted average sale price for the transaction reported was $63.6389, and the range of prices were between $63.51 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 99,716 | $63.26 | $6,307,964.36 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 7 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,011 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F5 · price: The weighted average sale price for the transaction reported was $63.2593, and the range of prices were between $62.51 and $63.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 16, 2026 Filed Sep 18, 2026 01:31 UTC |
Dube Eric MDirector · CHIEF EXECUTIVE OFFICER
|
Exercise / conversionCommon Stock | 195,841 | $23.34 | $4,570,928.94 |
DisclosureSEC source: 0001763494-26-000007 · form4-09182026_010928.xml · nonDerivative · entry 6 Dube Eric M · CIK 0001763494 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 628,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 39,650 | $0.00 Strike: $17.96 | $0.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 13 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 350 Underlying: Common Stock · 39,650 shares Expires 2029-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 39,000 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · derivative · entry 12 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 39,000 shares Expires 2028-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 270 | $65.31 | $17,633.70 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 6 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,197 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 3,000 | $63.65 | $190,952.40 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 5 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,467 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F5 · price: The weighted average sale price for the transaction reported was $63.6508, and the range of prices were between $63.49 and $63.99. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 29,021 | $62.66 | $1,818,316.56 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 4 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,467 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F4 · price: The weighted average sale price for the transaction reported was $62.6552 and the range of prices were between $62.41 and $63.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
SaleCommon Stock | 63,907 | $61.99 | $3,961,850.56 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 3 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,488 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F3 · price: The weighted average sale price for the transaction reported was $61.994, and the range of prices were between $61.405 and $62.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 39,650 | $17.96 | $712,114.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 2 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 194,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
ROTE WILLIAM E.Chief Research Officer
|
Exercise / conversionCommon Stock | 39,000 | $25.25 | $984,750.00 |
DisclosureSEC source: 0001698262-26-000005 · form4-09182026_010952.xml · nonDerivative · entry 1 ROTE WILLIAM E. · CIK 0001698262 · Chief Research Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 271 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 36,526 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 17 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,474 Underlying: Common Stock · 36,526 shares Expires 2034-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 1,381 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 16 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,119 Underlying: Common Stock · 1,381 shares Expires 2033-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 39,283 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · derivative · entry 15 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,217 Underlying: Common Stock · 39,283 shares Expires 2031-01-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 1,431 | $65.31 | $93,457.61 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 7 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 117,066 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F6 · price: The weighted average sale price for the transaction reported was $65.3093, and the range of prices were between $65.30 and $65.31. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 1,400 | $63.65 | $89,112.94 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 6 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 118,497 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F5 · price: The weighted average sale price for the transaction reported was $63.6521, and the range of prices were between $63.56 and $63.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 27,421 | $62.59 | $1,716,379.11 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 5 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,897 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F4 · price: The weighted average sale price for the transaction reported was $62.5936, and the range of prices were between $62.43 and $63.27. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
SaleCommon Stock | 71,938 | $62.05 | $4,463,875.19 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 4 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 147,318 F2 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F3 · price: The weighted average sale price for the transaction reported was $62.0517, and the range of prices were between $61.43 and $62.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 36,526 | $8.93 | $326,177.18 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 3 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 219,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,381 | $22.40 | $30,934.40 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 2 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,730 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:35 UTC |
Heerma PeterEVP, CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 39,283 | $26.88 | $1,055,927.04 |
DisclosureSEC source: 0001789617-26-000004 · form4-09182026_010901.xml · nonDerivative · entry 1 Heerma Peter · CIK 0001789617 · EVP, CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,382 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:33 UTC |
Inrig JulaEVP, Head of R&D & CMO
|
Exercise / conversionEmployee stock option (right to buy) · Derivative | 32,395 | $0.00 Strike: $8.93 | $0.00 |
DisclosureSEC source: 0001902368-26-000008 · form4-09182026_010947.xml · derivative · entry 6 Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,605 Underlying: Common Stock · 32,395 shares Expires 2034-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:33 UTC |
Inrig JulaEVP, Head of R&D & CMO
|
SaleCommon Stock | 400 | $65.31 | $26,124.00 |
DisclosureSEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 5 Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,491 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:33 UTC |
Inrig JulaEVP, Head of R&D & CMO
|
SaleCommon Stock | 1,600 | $63.69 | $101,896.00 |
DisclosureSEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 4 Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,891 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F4 · price: The weighted average sale price for the transaction reported was $63.685, and the range of prices were between $63.58 and $63.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:33 UTC |
Inrig JulaEVP, Head of R&D & CMO
|
SaleCommon Stock | 17,284 | $62.62 | $1,082,396.67 |
DisclosureSEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 3 Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,491 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F3 · price: The weighted average sale price for the transaction reported was $62.6242, and the range of prices were between $62.40 and $63.365. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
| September 15, 2026 Filed Sep 18, 2026 01:33 UTC |
Inrig JulaEVP, Head of R&D & CMO
|
SaleCommon Stock | 25,390 | $62.02 | $1,574,604.01 |
DisclosureSEC source: 0001902368-26-000008 · form4-09182026_010947.xml · nonDerivative · entry 2 Inrig Jula · CIK 0001902368 · EVP, Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 119,775 F1 · kind: This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. F2 · price: The weighted average sale price for the transaction reported was $62.0167, and the range of prices were between $61.40 and $62.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.